Saturday, February 23, 2019

Amazon scraps secret AI recruiting tool that showed bias against women | Reuters

Amazon scraps secret AI recruiting tool that showed bias against women | Reuters





Amazon scraps secret AI recruiting tool that showed bias against women

SAN FRANCISCO (Reuters) - Amazon.com Inc's (AMZN.O) machine-learning specialists uncovered a big problem: their new recruiting engine did not like women.

The team had been building computer programs since 2014 to review job applicants' resumes with the aim of mechanizing the search for top talent, five people familiar with the effort told Reuters.

Automation has been key to Amazon's e-commerce dominance, be it inside warehouses or driving pricing decisions. The company's experimental hiring tool used artificial intelligence to give job candidates scores ranging from one to five stars - much like shoppers rate products on Amazon, some of the people said.

"Everyone wanted this holy grail," one of the people said. "They literally wanted it to be an engine where I'm going to give you 100 resumes, it will spit out the top five, and we'll hire those."

But by 2015, the company realized its new system was not rating candidates for software developer jobs and other technical posts in a gender-neutral way.

That is because Amazon's computer models were trained to vet applicants by observing patterns in resumes submitted to the company over a 10-year period. Most came from men, a reflection of male dominance across the tech industry. 

In effect, Amazon's system taught itself that male candidates were preferable. It penalized resumes that included the word "women's," as in "women's chess club captain." And it downgraded graduates of two all-women's colleges, according to people familiar with the matter. They did not specify the names of the schools.

Amazon edited the programs to make them neutral to these particular terms. But that was no guarantee that the machines would not devise other ways of sorting candidates that could prove discriminatory, the people said.

The Seattle company ultimately disbanded the team by the start of last year because executives lost hope for the project, according to the people, who spoke on condition of anonymity. Amazon's recruiters looked at the recommendations generated by the tool when searching for new hires, but never relied solely on those rankings, they said.

Amazon declined to comment on the technology's challenges, but said the tool "was never used by Amazon recruiters to evaluate candidates." The company did not elaborate further. It did not dispute that recruiters looked at the recommendations generated by the recruiting engine.

The company's experiment, which Reuters is first to report, offers a case study in the limitations of machine learning. It also serves as a lesson to the growing list of large companies including Hilton Worldwide Holdings Inc (HLT.N) and Goldman Sachs Group Inc (GS.N) that are looking to automate portions of the hiring process.

Some 55 percent of U.S. human resources managers said artificial intelligence, or AI, would be a regular part of their work within the next five years, according to a 2017 survey by talent software firm CareerBuilder.

FILE PHOTO: Brochures are available for potential job applicants at "Amazon Jobs Day," a job fair at the Amazon.com Fulfillment Center in Fall River, Massachusetts, U.S., August 2, 2017. REUTERS/Brian Snyder/File Photo

Employers have long dreamed of harnessing technology to widen the hiring net and reduce reliance on subjective opinions of human recruiters. But computer scientists such as Nihar Shah, who teaches machine learning at Carnegie Mellon University, say there is still much work to do.

"How to ensure that the algorithm is fair, how to make sure the algorithm is really interpretable and explainable - that's still quite far off," he said.

MASCULINE LANGUAGE

Amazon's experiment began at a pivotal moment for the world's largest online retailer. Machine learning was gaining traction in the technology world, thanks to a surge in low-cost computing power. And Amazon's Human Resources department was about to embark on a hiring spree: Since June 2015, the company's global headcount has more than tripled to 575,700 workers, regulatory filings show.

So it set up a team in Amazon's Edinburgh engineering hub that grew to around a dozen people. Their goal was to develop AI that could rapidly crawl the web and spot candidates worth recruiting, the people familiar with the matter said.

The group created 500 computer models focused on specific job functions and locations. They taught each to recognize some 50,000 terms that showed up on past candidates' resumes. The algorithms learned to assign little significance to skills that were common across IT applicants, such as the ability to write various computer codes, the people said.

Instead, the technology favored candidates who described themselves using verbs more commonly found on male engineers' resumes, such as "executed" and "captured," one person said.

Gender bias was not the only issue. Problems with the data that underpinned the models' judgments meant that unqualified candidates were often recommended for all manner of jobs, the people said. With the technology returning results almost at random, Amazon shut down the project, they said.

THE PROBLEM, OR THE CURE?

Other companies are forging ahead, underscoring the eagerness of employers to harness AI for hiring.

Kevin Parker, chief executive of HireVue, a startup near Salt Lake City, said automation is helping firms look beyond the same recruiting networks upon which they have long relied. His firm analyzes candidates' speech and facial expressions in video interviews to reduce reliance on resumes.

"You weren't going back to the same old places; you weren't going back to just Ivy League schools," Parker said. His company's customers include Unilever PLC (ULVR.L) and Hilton.

Goldman Sachs has created its own resume analysis tool that tries to match candidates with the division where they would be the "best fit," the company said.

Microsoft Corp's (MSFT.O) LinkedIn, the world's largest professional network, has gone further. It offers employers algorithmic rankings of candidates based on their fit for job postings on its site.

Still, John Jersin, vice president of LinkedIn Talent Solutions, said the service is not a replacement for traditional recruiters.

"I certainly would not trust any AI system today to make a hiring decision on its own," he said. "The technology is just not ready yet."

Some activists say they are concerned about transparency in AI. The American Civil Liberties Union is currently challenging a law that allows criminal prosecution of researchers and journalists who test hiring websites' algorithms for discrimination.

"We are increasingly focusing on algorithmic fairness as an issue," said Rachel Goodman, a staff attorney with the Racial Justice Program at the ACLU.

Still, Goodman and other critics of AI acknowledged it could be exceedingly difficult to sue an employer over automated hiring: Job candidates might never know it was being used.

As for Amazon, the company managed to salvage some of what it learned from its failed AI experiment. It now uses a "much-watered down version" of the recruiting engine to help with some rudimentary chores, including culling duplicate candidate profiles from databases, one of the people familiar with the project said.

Another said a new team in Edinburgh has been formed to give automated employment screening another try, this time with a focus on diversity.

Reporting By Jeffrey Dastin in San Francisco; Editing by Jonathan Weber and Marla Dickerson



Elyssa D. Durant
Policy & Research Analyst

Wednesday, February 20, 2019

The relationship between creativity and mood disorders

The relationship between creativity and mood disorders

The relationship between creativity and mood disorders

Dialogues in Clinical Neuroscience

Les Laboratoires Servier

Language: English | Spanish | French

La relatión entre creatividad y trastornos del ánimo

Nancy C. Andreasen, MD, PhD

Abstract

Research designed to examine the relationship between creativity and mental illnesses must confront multiple challenges. What is the optimal sample to study? How should creativity be defined? What is the most appropriate comparison group? Only a limited number of studies have examined highly creative individuals using personal interviews and a noncreative comparison group. The majority of these have examined writers. The preponderance of the evidence suggests that in these creative individuals the rate of mood disorder is high, and that both bipolar disorder and unipolar depression are quite common. Clinicians who treat creative individuals with mood disorders must also confronta variety of challenges, including the fear that treatment may diminish creativity, in the case of bipolar disorder, hovt/ever, it is likely that reducing severe manic episodes may actually enhance creativity in many individuals.

Keywords: creativity, depression, mania, bipolar disorder, treatment

Anecdotally, there are many examples of striking associations between creativity and mood disorders, and particularly bipolar disorder. For example, Vincent. Van Gogh suffered from mood disorder during much of his short, adult, life, prior to committing suicide at. age 37. During the last year and a half of his life, he suffered from severe bouts of both psychotic mania and psychotic depression, yet he also produced more than 300 of his greatest works. Sylvia Plath, who also died by suicide at the young age of 31, suffered from severe mood disorder for much of her life. Although she was probably depressed at the time of her death, this period was preceded by a time when she worked late into the night and got up early in the morning, writing poetry intensely - and often poetry with a wry, dry sense of humor, suggesting intermittent periods of a manic or hypomanic state. Martin Luther suffered periods of intense despair, but also periods of extremely high energy. After his Ninety-five Theses unexpectedly launched the Reformation, he devoted enormous energy to writing theological tracts to defend his position. There are many other well-known creative people who suffered from mood disorders, many of them bipolar: Ernest Hemingway, Winston Churchill, and Theodore Roosevelt, to mention only a few.

Anecdotal accounts of the lives of creative people are fascinating, because they convey a human and personal element. They also suggest, that examining the association between creativity and mood disorders is an interesting scientific pursuit. However, the real test of whether there is an association can only be determined by rigorous empirical studies. Such studies are relatively rare, however, because research on the nature of creativity presents a variety of challenges.

Challenges in studying creativity

One of the greatest challenges faced by creativity researchers is defining the nature of the sample to be studied. The use of the term "creativity" to refer to individuals who make creative contributions is relatively modern. Up until the early 20th century, such individuals were said to have "genius." For example, the landmark study of Lewis Terman, who prospectively followed a group of highly gifted children over many decades, was called "Genetic Studies of Genius."1 In this particular study "genius" was defined as having a high intelligence quotient (IQ) on the TQ tests that Terman had developed. Interestingly, as Terman and his group followed these high-IQ individuals into adulthood, they observed that they were generally more successful than average, but that very few actually made significant, creative contributions, thereby documenting that having a high IQ is a different mental trait, than being creative. Other early studies by Lombroso, Ellis, and Galton also used the term "genius."2-4 In these works genius was seen as roughly equivalent to being eminent, in a variety of fields. Ellis, for example, chose to study people whose lives were described in the British Dictionary of National Biography and who had entries longer than three pages. This of course provided him with a very mixed group of people, ranging from politicians to industrialists to artists and scientists, not all of whom would be considered to be creative in current usage.

These early efforts suggest that a better definition of the term "creativity" may be the key to identifying an appropriate sample to study Many different, perspectives have been offered on defining creativity by authors such as Howard Gardner or Mihaly Csikszentmihalyi. Gardner argues persuasively that there multiple types of creativity, which he refers to as "multiple intelligences."5 A key component, of Gardner's approach is that he disagrees with the common stereotype that makes creativity equivalent to pursuing work in the arts, and ignores the fact that people in fields such as engineering or biology also may be highly creative. Csikszentmihalyi stresses the importance of making original contributions and of being recognized for these contributions by one's peers.6 Although there are some differences between those cur rently pursuing research on creativity, a definition that most, would embrace is one that emphasizes that creativity is the ability to produce something that is novel and also useful or beautiful in a very general sense.7 Some would also emphasize the importance of having achieved some kind of public recognition for this work, such as a Pulitzer Prize, a listing in Who's Who in Art, or a Fields Medal. However, this is a relatively stringent criterion.

Given this definition of creativity, how then should an investigator identify a sample to study? One approach is to select a very homogeneous group of creative people, such as a group of writers, or musicians, or mathematicians. This is perhaps the most common. Another approach is to sample more broadly and to study a mixture of creative individuals from multiple disciplines. The most difficult aspect, of this type of research is identifying and recruiting the subjects, since creative people tend to be relatively busy.

An alternative approach is to identify a group of people for whom written histories are available and to use this information as the basis for study. Examples of this type of approach are the studies of Ellis, Juda, Post, Ludwig, and Schildkraut.3, 8-11 Although using written historical biographical and autobiographical material provides a sample of convenience, an obvious problem is that the information may not be complete or accurate.

If the goal of a study is to examine the relationship between creativity and psychopathology, then several other challenges must, also be met. One is to use a standard and widely accepted set of definitions of mental illness, and to assess its presence or absence using a structured interview of some type. Although this seems obvious in the early 21st century, most of the extant literature on creativity and mental illness has not used this approach. It is nearly impossible to map the diagnoses of early investigators, such as Adele Juda, into modern nomenclature, and therefore to interpret the results. A second challenge is to identify an appropriate comparison or control group, in order to determine whether rates of any given illness in the creative people are different from rates in a "normal" comparison group. Selecting the comparison group is also a challenge. Should one select a profession not notable for nurturing creativity, such as lawyers? Should one select a varied group of people not known to be creative, who are equivalent in age, gender, and educational level to the creative group? There is no easy answer, but the latter alternative is probably preferable, since it "averages out." whatever bias might exist if a single field or profession were chosen.

Is there an association between mood disorders and creativity?

The earliest solidly empirical study to examine the relationship between creativity and mental illness was conducted using a sample of 15 writers from the University of Iowa Writers' Workshop and 15 control subjects of equivalent, age, gender, and educational achievement.12 Over the years the sample was steadily expanded, so that the final study consisted of 30 subjects in each group.13 Subjects were evaluated using a structured interview, and diagnoses were made using the Diagnostic and Statistical Manual of Mental Disorders. 3rd ed (DSM III) 14 criteria. The results of this study are summarized in Table I. Rates of mood disorder are extremely high in the writers; 80% had some type of mood disorder, and 30% had either bipolar I or bipolar II disorder. Both these rates are significantly different from the control subjects. The writers also had higher rates of alcohol abuse than the controls. This study has been replicated by several other investigators. In 1989 Jamison reported her work examining British writers and artists.15 They were selected using the criterion of having won major honors or prizes in their field, such as membership in the Royal Academy, the Booker Prize, or the New York Drama Critics' Award. Diagnostic criteria were not used in this study; instead subjects were classified as suffering from mood disorder based on whether they had received treatment. The subjects were subdivided into five groups: novelists (8), poets (18), playwrights (8), biographers (5), and artists (8). Overall, 38% of the sample had been treated for a mood disorder. The highest rate of treatment was in the playwrights (63%), but more than half had received psychotherapy rather than medication. The poets had the highest rate of needing medication for mood disorder (33%); they were also the only group to have received treatment for mania. This study did not include a control group, so statistical comparisons cannot be made between the creative individuals and a comparable comparison group. Although a relatively small subset of the sample had been treated for bipolar disorder, Jamison describes a variety of types of mood swings in this sample.

Table I.

Psychiatic illness in writers versus controls. ns, non significant

A subsequent study, published by Ludwig in 1994, also examined creativity in writers.16 He studied 59 women writers who were participants in the national Women Writers' Conference held annually at. the University of Kentucky. He selected age and educationally matched controls from members of several different women's clubs within the state, such as a county medical auxiliary or a statewide homemaker's association. Evaluations were extensive and included a screening questionnaire designed to evaluate the presence of psychiatric syndromes, followed by a personal interview; diagnostic criteria were based on Diagnostic and Statistical Manual of Mental Disorders. 3rd cd revised (DSM-lll-R).17 The two groups differed significantly in rates of a variety of diagnoses, including depression, mania, panic attacks, generalized anxiety, and drug abuse. Rates were always higher in the writers. Rates of depression (56%) and mania (19%) were both relatively high.

These three studies are the primary ones to investigate rates of mood disorders in creative individuals using personal interviews of the subjects and a diagnosis that reflects modern concepts of depression and bipolar disorder. While they vary slightly in the lifetime prevalence rates reported, all results run in the same direction. Thus, it seems likely that creative individuals do have higher rates of mood disorder in general, and bipolar disorder in particular. An obvious limitation of the work to date, however, is that it has focused primarily on writers. A study to determine whether these results generalize to other types of creativity (eg, inventors, performing artists, scientists) is yet to be done.

Psychiatric treatment of creative individuals suffering from bipolar disorder

Given that there appears to be a clear association between creativity and mood disorder, what, are the implications for the clinician who is caring for a creative individual who suffers from mania or depression? Specifically, how does treatment affect an individual's capacity to be creative? This is a matter of some concern to patients, particularly those in the bipolar spectrum. Some feel that the high energy levels and euphoria associated with manic or hypomanic states enhance creativity and may be reluctant, to have their euphoria blunted by psychotropic medications. Further, it has been argued that experiencing depression may also increase the creative capacity in some individuals. For example, Sir George Pickering has argued that while depressed a creative person may be in an incubation phase during which ideas may grow18 This is then followed by a very creative period after the person emerges from the depression; he cites Charles Darwin, Mary Baker Eddy, Marcel Proust, Sigmund Freud, Florence Nightingale, and Virginia Woolf as examples. Such examples are, of course, anecdotal.

There are also many examples of anecdotal accounts indicating that, creative individuals who have suffered from mood disorders find them to be disruptive and counterproductive. Among the writers in the Iowa Workshop study, essentially all of them reported that they were unable to work creatively during periods of depression or mania. During depressive episodes their cognitive fluency and energy were decreased, and during manic periods they were too distractible and disorganized to work effectively. Other writers have also reported a similar inhibiting effect of mood disorder. One of the most famous public examples is Robert. Lowell, a great American poet, of the 20th century who suffered from severe bipolar disorder. In his biography of Lowell, Ian Hamilton described how Lowell found himself to be more creative after being placed on lithium.19

This had been the first year in eighteen he hadn't had an attack. There had been fourteen or fifteen of them over the past eighteen years. Frightful humiliation and waste.... Now it was a capsule a day and once-a-week therapy.

Very little empirical work has been done on this subject. It was of interest, to Mogens Schou, who was largely responsible for developing lithium as a treatment for bipolar disorder.20 He studied a group of 24 artists (a mixture of writers, composers, and painters). Using measures of productivity and quality of work, he found that the artists fell into three groups. Half of the subjects (12) showed great improvement; these were people who had very severe bipolar illness (much like Robert Lowell) and found that, treatment actually enhanced their ability to create. A second group (N=6) had unaltered productivity. A third group - 6 people, or 25% of the sample - had lowered productivity, although this did not necessarily occur throughout the period of treatment. Overall these results suggest that adequate and appropriate treatment is likely to be helpful for the majority of creative people suffering from bipolar disorder.

The clinician who treats creative people with mood disorders must of course be a sensitive and supportive listener. Patients are likely to work best if the psychiatrist understands the challenges and difficulties that creative people confront in the pursuit, of their art.21 Creative people tend to push the limits and live on the edge. As the saying goes, "when you work at the cutting edge, you are likely to bleed." An additional concern is the high rate of suicide and suicide attempts among creative people. This is a consistent theme in much of the creativity research conducted to date.22 Losing gifted individuals to suicide is a profound tragedy, and clinicians must also be aware of this risk in their treatment planning.

Summary

There appears to be a strong association between creativity and mood disorders. However, the overall literature supporting this association is relatively weak. A great deal of the work reported suffers from inadequate definitions of both creativity and mood disorders, reliance on anecdotal and autobiographical or biographic sources, and a lack of control groups. The range of types of creativity studied to date has also been relatively narrow. It has focused largely on writers. The study of the relationship between creativity and mental illnesses is still a relatively open territory, with much remaining to be done.

Notes

The present study was performed at the University of lowa, lowa City, IA, USA, under the folowing grant support: NARSAD

Article information

Dialogues Clin Neurosci. 2008 Jun; 10(2): 251–255.

Nancy C. Andreasen, Andrew H. Woods Chair of Psychiatry, Department of Psychiatry, University of Iowa Health Care, and the Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa, USA;

Articles from Dialogues in Clinical Neuroscience are provided here courtesy of Les Laboratoires Servier

REFERENCE

1. Terman L., Cox C., Oden M., Burks B., Jensen D. Genetic Studies of Genius. Stanford, Calif: Stanford University Press; :1925–1959.

2. Loinbroso C. The Man of Genius. London, UK: Walter Scott; 1891

3. Ellis HA. A Study of British Genius. New York, NY: Houghton-Mifflin; 1926

4. Gallon F. Hereditaiy Genius. London, UK: Macmillan and Company; 1892

5. Gardner H. intelligence Reframed: Multiple intelligences for the Twenty-First Century. New York, NY: Basic Books; 1999

6. Csikszentmihalyi M. Creativity: Flow and the Psychology of Discovery and Invention. New York, NY: Harper Collins; 1996

7. Andreasen NC. The Creating Brain: The Neuroscience of Genius. New York, NY: Dana Press; 2005

8. Juda A. The relationship between high mental capacity and psychic abnormalities. Am J Psychiatry. 1949;106:296–307. [PubMed]
9. Post F. Creativity and psychopathology. A study of 291 world-famous men. . Br J Psychiatry. 1994;165:22–34. [PubMed]
10. Ludwig AM. Creative achievement and psychopathology: comparison among professions. . Am J Psychotherapy. 1992;46:330–356. [PubMed]
11. Schildkraut JJ., Hirshfeld AJ., Murphy JM. Mind and mood in modern art, II: Depressive disorders, spirituality, and early deaths in the abstract expressionist artists of the New York School. . Am J Psychiatry. 1994;151:482–488. [PubMed]
12. Andreasen NC., Canter A. The creative writer: psychiatrie symptoms and family history. . Cornp Psychiatry. 1974;15:123–131. [PubMed]
13. Andreasen NC. Creativity and mental illness: prevalence rates in writers and their first-degree relatives. . Am J Psychiatry. 1987;144:1288–1292. [PubMed]

14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980

15. Jamison KR. Mood disorders and patterns of creativity in british writers and artists. . Psychiatry. 1989;52:125–134. [PubMed]
16. Ludwig AM. Mental illness and creative activity in female writers. . Am J Psychiatry. 1994;151:1650–1656. [PubMed]

17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987

18. Pickering G. Creative Malady. New York, NY: Oxford University Press; 1974

19. Hamilton I. Robert Lowell: a Biography. New York, NY: Random House; 1982

20. Schou M. Artistic productivity and lithium prophylaxis in manic-depressive illness. Br J Psychiatry. 1979;135:56–65. [PubMed]
21. Andreasen NC., Glick ID. Bipolar affective disorder and creativity: Implications and clinical management. . Comp Psychiatry. 1988;29:207–217. [PubMed]

22. Jamison KR. Touched With Fire. . Manic-Depressive Illness and the Artistic Temperament. New York, NY: The Free Press; 1993



Elyssa D. Durant 
Research & Policy Analyst

Bipolar? Or Gifted? – The Modern Day Epidemic Of Medicated "Madness" | Wake Up World

Bipolar? Or Gifted? – The Modern Day Epidemic Of Medicated "Madness" | Wake Up World



Bipolar? Or Gifted? – The Modern Day Epidemic Of Medicated "Madness"

Bipolar or Gifted – The Modern Day Epidemic Of Medicated Madness

By Cortland Pfeffer (with Irwin Ozborne)

Contributing writers for Wake Up World

"Have I gone mad?" asked the Mad-Hatter. "I'm afraid so, you're entirely bonkers", Alice replied, "but I'll tell you a secret… all the best people are."

The exchange above is from Lewis Carroll's notorious fictional story, Alice in Wonderland, which in my professional opinion stands with more validity than today's psychiatric and mental health paradigms. In fact, Alice shares the same view as some of the greatest thinkers of all-time, such as Socrates who once declared: "Our greatest blessings come to us by way of madness, provided the madness is given us by divine gift." Plato too referred to insanity as "a divine gift and the source of the chief blessings granted to men."

So, to best understand bipolar disorder the modern day epidemic of medicated "madness", down the rabbit hole we go…

Down the Rabbit Hole

Going back to our friend Alice, on the first page of the classic story, we find Alice is disinterested in the dull, boring, everyday existence in which she resides. She peers into her sister's book to see it has no illustrations or even conversations, which to Alice has no use or interest. She ponders the idea of making a daisy-chain, but lacks the energy or motivation to take the time to pick the daisies. She is disinterested in 'normal' life. Then, suddenly, a talking white-rabbit runs past her; he appears to be late. Of course, Alice is curious about this bizarre occurrence and follows him down the rabbit hole — and most of us will be familiar with the rest of the story.

By today's standards and diagnostic references, Alice's disinterest in 'normal' life would very likely be diagnosed as a mental disorder. With this diagnosis, she would then be medicated for life, after a brief stay at a psychiatric hospital to stabilize her on the medications that are claimed to be capable of normalizing her mental sickness.

But, is Alice really sick? Or is she a creative, intelligent, deep-thinking, imaginative, or even gifted child? I would wager everything I own on the latter!

Bipolar disorder is one of the oldest recognized 'mental disorders', yet it remains one of the most misunderstood. As a psychiatric Registered Nurse, it is my belief that people with bipolar disorder are not "sick" – the real sickness lies in the treatment and medications they receive.

What is Bipolar Disorder?

Formerly known as manic-depressive disorder or manic-depression, bipolar disorder refers to the experience of opposing poles with regard to a person's mood. Essentially, bipolar disorder is distinguished by the experience of polarity.

At one pole is mania, which includes intense energy, racing thoughts, feelings of euphoria, inflated grandiosity or sense of self, impulsiveness and risk-taking behavior. The other pole includes depression, which presents the opposite symptoms, such as fatigue (to the point of inability to get out of bed), moving or talking so slowly that others notice, a feeling of emptiness, loss of interest in things that were once enjoyable, difficulty concentrating or making decisions, and thoughts of self-harm.

It is important to understand the distinction between moods and emotions here. Moods are essentially emotional feelings that last for a period of time – typically for more than two or three days, which can be difficult to shift. While everyone has their ups-and-downs, bipolar disorder is far more disabling, with symptoms far more severe than a typical mood swing from happiness to sadness. The extremes of bipolar disorder can take you from feeling that you are omnipotent to the point of wanting to end your own life.

Inside The Bipolar Mind

"It is no measure of health to be well adjusted to a profoundly sick society" ~ Krishnamurti

Just as Alice does in the opening chapter of her story, many people with bipolar disorder realize that "normal life" is far too phony, boring and constrained. They realize that there is much more to this mundane existence than what is commonly suggested. So, with this insight, one can see how easily it would be to slip into a depressed mood with thoughts such as:

– Why would I want to go through with this life?
Nobody understands me!
– I am all alone.
Why am I the only one who thinks this way?
Maybe they are right, maybe I am crazy.
What is the point of it all?
– What reason do I have to keep going?

This depression sucks the life out of you, to the point that you lack the energy to even get up and pour a glass of water. If I got up, then I would have to find a glass, wait for the water to filter, and then put the glass away… it is not worth the effort. Furthermore, the person experiencing these thoughts realizes that this thought process is illogical, and destructive, which only creates a tidal-wave effect, inducing further feelings of sadness and dejection.

How Does Bipolar Come On?

At birth, we are free — we are born with a clean slate and we see the world is magical. But as we grow, things change. We are trained to behave a certain way; we are domesticated to a set of standards that our society has agreed are "normal". We learn to create a mask and put it on every day; To  conform. We learn to use different masks for different groups of people, different occasions, and different times. We are taught that this is "normal life", and that wearing these masks is "normal" human behavior.

bipolar_disorder

And yet this mask, this image that we create and send out to the world, is our false self. It is a learned function of the ego. It is only behind the mask that we find our true self — our soul.

Manic episodes — those times of euphoria, grandiosity and impulsiveness — are triggered by the collapsing of the ego or mask. It is as though the soul is allowed to be free for the first time. Just like a dog that is tied to a chain its entire life and then finally breaks free, it runs wild, explores, and does whatever it can, because it can finally be the animal it was meant to be.

A spiritual awakening is much the same process. Like those times of mania, it involves taking off the mask and living as our true self for the first time. If treated as a spiritual dis-ease, this is the unexpected gift that bipolar disorder can offer — a short-cut to enlightenment. The mania pole can reveal to us our strongest and deepest desires, and exactly how our personal energy truly wishes to be expressed, while the depression pole shows us – in no uncertain terms – the areas of our lives that are not being lived in total alignment with our most honest truth.

But, like the dog that just got off its leash and is running wild without care, there can be great danger if those manic episodes that are not controlled. Experiencing and freely expressing the impulses of your true self for the first time, you may begin to test reality in life-threatening ways, such as trying to fly out a window, walking into the middle of traffic, etc. In contrast, if the dog (the soul) has always been allowed to roam freely, it learns not to run in traffic or to chase people, and knows how to regulate its natural energy and exuberance for life.

The key is balance; learning always to roam free, not just in moments of mania.

Bipolar Disorder: Science, Medicine, and Statistics

According to the National Institute of Mental Health (NIMH), 5.7 million Americans (or 2.6 percent of the population) have bipolar disorder.[1] This is the highest rate of any country in the world. The official position of the NIMH is also that bipolar disorder cannot be cured. As stated on the NIMH website:

"Bipolar disorder cannot be cured… Because it is a lifelong illness, long-term, continuous treatment is needed to control symptoms." [2]

With the United States having the highest prevalence of bipolar disorder, which is deemed incurable by the mental health establishment, it would make sense that the United States would have the finest diagnostic tools and science available, wouldn't it? However, contrary to popular belief, there is no science involved in the diagnosis of bipolar disorder, rather it is diagnosed from a subjective set of criteria. There are no scans or medical tests, nor is there anything scientific about the process. Patients are simply asked questions in a brief consultation, and someone with a license makes a subjective interpretation as to whether or not they have a "lifelong, incurable disease".

The primary treatment for bipolar disorder is the prescription of psychotropic medication(s), mood-stabilizers, atypical antipsychotics, or antidepressant medications. A government study published in 2005 reported that just 11% of mental health facilities provided psychotherapy to all patients diagnosed with bipolar. [3]

Regrettably, the medical establishment's preference for treating bipolar disorder with medication over psychotherapy has less to do with results than one would like to think. When it comes to this disorder, it would seem psychiatric pay-checks and pharmaceutical profits rate far more highly than patients' needs. In the past, psychiatrists would tend to the needs of 40 to 50 clients at most, conducting 45-minute sessions with each one. Today, they see up to 1,200 clients, holding only 15-minute appointments that focus on refilling medication prescriptions.

Why Are So Many Diagnosed with Bipolar?

In 1955, about one in every 13,000 people was diagnosed with bipolar disorder or manic-depression. [4] Today, that number has skyrocketed to nearly one in every forty!

Are there really that many more people displaying symptoms of such a disease, or could there be another factor accounting for this sharp rise in diagnoses? Let's look at some statistics:

  • In 1970, the U.S. Food & Drug Administration approved the first mood-stabilizer medication Lithium (although many U.S. physicians were already prescribing it in the late 1960's without seeking an investigational new drug permit (IND) from the FDA, meaning its initial introduction to the U.S. population was entirely unregulated.) Following the official release of this new medication, an increase in the rate of official diagnoses of bipolar disorder naturally followed.
  • In 1995 Zyprexa was the first of the atypical antipsychotic medications approved for treatment of mania, and again, a surge in diagnosis ensued.
  • America is home to only 5% of the world's population, yet it is currently prescribed more than 50% of all pharmaceutical drugs worldwide.
  • In 1976, Americans owned just 18.4% of the world market-share in pharmaceutical interests, but by the year 2000, that figure had climbed to 52.9%. [5]
  • In 2001, worldwide revenue for pharmaceutical drugs was around $390.2 billion U.S. Ten years later (2011), this figure stood at almost one trillion U.S. dollars.

With BIG money to be made from the prescription of pharmaceutical drugs, it's not difficult to see why the mental health establishment's treatment of bipolar disorder with psychotherapy waned — It was a question of financial incentive not effective treatment.

While United States has the highest rate of lifetime diagnosis of bipolar disorder, population-based surveys show that New Zealand is in second place [6], where a startling rate of almost 5% of the nation's Maori (indigenous) population is diagnosed with bipolar disorder. Outside the U.S. and New Zealand, no other country even comes close.

Importantly, high bipolar rates are not the only thing these two countries have in common. In 1997, the United States became the second country — New Zealand was the first — to allow Direct-to-Consumer (DTC) advertising of pharmaceuticals, enabling drug companies to advertise their products directly to consumers. [7] By doing so, the U.S. FDA loosened the regulatory chains that previously kept drug companies in check, allowing them to advertise their "products" on television, radio and other media. This kind of marketing (like all mass-marketing) creates a sense of need where one previously did not exist; it allows the consumer to become familiar with the drugs available and their supposed "benefits", to specifically ask their doctor for that medication, and if the doctor refuses, to find another doctor that will fulfil their request.

Of course none of this has anything to do with science. What it does involve is a multi-million dollar marketing scheme. And if you wonder why you never hear anything about this on the TV news, that's because doing so would constitute a massive conflict of commercial interests for the media corporations that are heavily funded by pharmaceutical advertising. And despite the clear conflict of moral interests here, media corporations and the shareholders who ultimately benefit from this kind of direct-to-consumer marketing, prefer not to bite the hand that feeds them.

Are Prescription Drugs Actually Helping?

Psychotropic pharmaceutical drugs, like all drugs, can initially relieve symptoms of bipolar disorder, in the same way that alcohol or any number of illicit substances can be used to mask symptoms. Such substances artificially relieve us of unwanted feelings or states of mind, by affecting the brain's chemistry. But as with all consciousness-altering drugs, relief is only temporary. You only get to 'rent the relief'. In other words, everything that the drug gives you will eventually have to be paid back at some time.

The brain is always working to create balance – known as homeostasis – and when conditions change, the brain's neurology also changes. Therefore the perceived positive effects of pharmaceutical intervention are therefore short-lived.

According to the reductionist medical and mental-health paradigms, a medication is deemed successful when the patients's symptoms diminish. Although the do nothing to address the root cause of psychosis, antipsychotic drugs can remove or mask the symptoms at first. This is the same principle that applies to alcohol, which can temporarily remove feelings of anxiety or depression — but it is by no means a long-term solution. In fact, what happens is that the brain quickly develops a tolerance to the substance and the individual taking it then needs more of the drug in order to feel the same effects. Eventually, a threshold is reached at which the individual no longer feels any effect and cannot be prescribed an increased dosage; the drug becomes the 'new normal'. Then, when you try to stop taking the drug, your body suffers serious physical, mental, and emotional effects, because it has grown dependent on it. The body then needs to create homeostasis again, to cope without the drug. This is what is known as withdrawal.

In an August 2014 letter to The Psychiatric Times, psychiatrist Sandra Steingard M.D. (the Medical Director of Howard Center and Clinical Associate Professor of Psychiatry at the University of Vermont College of Medicine in Burlington) compared a number of different studies that demonstrate just how those suffering bipolar disorder and other psychoses are actually more effectively treated without antipsychotic drugs. She compared studies of individuals who stayed on antipsychotic drugs with studies of those who stopped using the medications after a period of two years.

According to Dr. Steingard's research, after two years the results were initially fairly even, with 74% of those who stayed on antipsychotic medications showing psychotic symptoms, compared with the 60% of individuals showing psychotic symptoms in the group that stopped taking their medications after two years. However, as time went on, the gap grew exponentially larger. At 4½ years, 86% of those who continued to take the medications displayed psychotic symptoms, compared to 21% of those who continued to abstain after the two year mark. And after 20 years, the difference was 68% compared to 8% respectively.[8] Says Dr. Steingard:

This raises troubling questions for psychiatry… Psychiatrists are assigned a powerful role in our society; we can force patients into treatment, and this sometimes includes forcing them to take these drugs… In taking on this task, it seems that psychiatry should be assiduous in assessing risk and utterly transparent in our disclosures. This risk includes not only the failure to treat but also the consequences of our treatments. Yet, this has not been our history. Our profession has been slow to address the limitations of our drugs. We were slow to acknowledge tardive dyskinesia [a neurological disorder that occurs as the result of long-term or high-dose use of antipsychotic drugs] and slow to address the metabolic impacts of the newer antipsychotics. Will we be equally slow in addressing their impact on long-term recovery?

Clearly, pharmaceutical intervention is no solution to mental health disorders such as bipolar. All drugs, legal or illegal, have adverse effects on the body's chemistry. Yet, with the support of regulatory bodies such as the U.S. Food & Drug Administration, pharmaceutical companies label the desirable short-term effects as the "main" effects and the unwanted ones as "side effects." But, as the science has clearly demonstrated, all antipsychotic drugs will bring about changes in the body that are unnatural and undesirable, which ultimately prolong the suffering of the patient.

Blaming The Patients, Not The Drugs

We've all seen those stories on mainstream news where someone has committed a heinous or violent crime, and we are subsequently informed that the cause of their violence was because the individual did not follow their medication plan. The diagnosis of 'insanity' and the individual's failure to medicate is blamed as the cause for their psychotic behavior. But people in true psychosis are not typically violent; that perception is simply not true. It is generally once they stop taking their prescribed antipsychotic medications (perhaps due to the undesirable side-effects being experienced) that the withdrawal/side-effects create these suicidal or homicidal behaviors.

In other words, far from helping the patient, the taking of drugs as a "solution" to their condition actually leads to further problems, sometimes involving the tragic loss of life.

Drugging Adolescents and Children

Like all good product marketers, companies search for untapped markets and seek to create customers for life. This is known as 'cradle to grave' marketing; a corporate term that bears an eerie interpretation when viewed in the context of the medical and pharmaceutical industry.

In 1995, around 25 out of 100,000 adolescents aged 19 and under were diagnosed with bipolar disorder. By 2002, less than a decade later, that number had risen to 1,679 diagnoses out of 100,000 visits. [9] This increase is staggering! While the medical establishment shrugs its shoulders, unable to determine a scientific cause for such a sharp increase, realistically, the one factor that has actually changed in that time period is the ready availability and social acceptability of antipsychotic medications.

But this startling trend doesn't stop with adolescents; there has also been a steady increase in the diagnosis of pediatric bipolar disorder. Yes, you read that right – infants! In my experience, diagnosis goes a little like this:

Does your child act silly and crazy at some times? Then other times are they sad or angry? They might have bipolar disorder. Our drug can help you stabilize your child.

Kiddie Cocaine - FDA Approves New ADHD Amphetamine Drug Disguised as Candy

In reality, these young children do not have a diagnosable mood disorder — they are four-year-olds! Four-year-olds are simply not meant to always sit still, pay attention to one thing for extended periods, or regulate their own natural moods and emotions the way "socialized" adults do. Adding to this problem, up to 40 percent of U.S. schools are now cutting back on recess — the time when children get to go outside and be children!

And yet, prescribing antipsychotics has become the overwhelming norm, being regularly prescribed for so-called "behavioral disorders" like ADHD and ADD. According to Dr. Michelle Kmiec, an holistic health practitioner and regular contributing writer for Wake Up World:

Since 1990, according to some estimates, there has been a 300% increase with pharmaceuticals used to treat children diagnosed with ADHD. Now doesn't that statement alone scream that there is something wrong with our medical establishment? It seems the trend is not to question why so many children (and adults) are diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), but instead to simply keep developing more drugs to counteract the "symptoms".

Dr. Peter Breggin, a psychiatrist from Ithaca, N.Y., elaborates:

These drugs damage developing brains. We have a national catastrophe… This is a situation where we have ruined the brains of millions of children. In controlling behavior, antipsychotics act on the frontal lobes of the brain — the same area of the brain targeted by a lobotomy… These are lobotomizing drugs. Of course, they will reduce all behavior, including irritability.

It should also be noted that long-term use of the antipsychotic risperidone, commonly prescribed to young children, is associated with serious side effects including headache, uneven heartbeats, fatigue, insomnia, weight gain and increased risk for type 2 diabetes.

To complete this discussion today, I would like to share a personal account of my time with one of those 1,679 adolescents out of every 100,000 who are diagnosed as "mentally ill for life".

Jacob's Hope

"How can you say he is intelligent and gifted!?" shouts the mother of a 19-year-old adolescent, "He just tried to kill himself, talks crazy, and is emotionally unstable. Do not tell me he is intelligent!"

Jacob stormed out of the room, slammed the phone against the wall, and began pounding his fists into the corner of the room as if he were a caged animal begging to be set free. Quickly the entire hospital staff sprinted – following the culture and protocols of state hospitals – and Jacob was quickly restrained as though he were a criminal. Tears rolled down his cheek and onto the floor.

I was taken aback by what I just witnessed.

"They say I have bipolar disorder," Jacob told me later that afternoon. "They tell me that I am sick, that I need to be locked up here, and take these medications. I do not think I am sick, but I am not allowed to say that."

Believing he was a danger to himself and others, Jacob's family committed him to a state psychiatric hospital following what they believed to be "bizarre" comments and behavior they had witnessed.

"I don't think like them," Jacob told me, "All they care about is money. Money is worthless. I do not want to go to college. College is just a façade. They charge thousands of dollars to have you memorize information. They teach you what to think, not how to think. Those who get good grades are just robots, all they do is repeat what the teacher has told them. But I think the government is corrupt. I do not trust them. I do not want to work for my Dad's business. I want to travel the world, be a vagabond, read, write, and draw. I do not have any desire to work just to own material possessions. It is all phony."

As this continued, I realized that nothing this child told me was bizarre. In fact, I admired his ability to think freely – outside the box – and respected his deep understanding of his own reality. Jacob is not sick; he is misunderstood, creative, and actually quite gifted.

Other gifted individuals such as Vincent van Gogh, Ernest Hemmingway and Kurt Cobain shared the same diagnosis of bipolar disorder, and gave us some of the greatest art of their respective times. Sadly, each of the aforementioned also ended their own lives due to the depressive pole of the bipolar complex, which brought about overwhelming suicidal tendencies upon which (sadly) they acted.

Jacob had once attempted suicide too.

"There are no people like me. No one understands me. Nobody gets it", he told me when sharing the story of his suicide attempt, "So what is the point in being here? Everyone is living a fake life, chasing money to buy things they don't need, to impress people they don't like. That is not what life is about. I just need an escape from it all and sometimes it feels overwhelming."

Jacob asked to be taken off his medications because they made him feel like a zombie, feeling nothing at all, just going through the motions of life. But in the psychiatric world, any patient who shares an opinion such as this is simply labeled "resistant to treatment", and their medication dosage is increased. The only way to be successfully discharged from psychiatric institutionalization is to follow to the letter what the staff believes is best for you, entirely without your input.

For my own sanity, this is a game that I like to call "Saving Normal." Society and psychiatry have decided what normal is, with no scientific basis or understanding of the human condition, and then we tell ourselves that we are saving people by returning them to a state of mental normalcy.

Understanding his own nature better than any of the so-called experts on staff, Jacob stated that his goals were to stop taking medications, to discuss his feelings with people he trusted which he believed would help to minimize his feelings paranoia. But the staff would not allow it! Jacob was instructed that he can no longer talk about such things as the corruption of government, so he followed his orders and played the game, simply to get discharged.

But is such a protocol really helping people like Jacob? No. We are merely attempting to condition people like Jacob to 'be' what they need to be, to meet the expectations of society and to please the people who are empowered by government to run his life for him. This is why no one actually heals in the mental health system. This is why they come back, as life-long customers of the system. And when they do, we repeatedly try to force-feed them our beliefs about 'normal', medicate them out of their minds, and punish and restrain them for expressing their most intimate truth.

"I would like to be taken off my medications," Jacob presented to the staff, "I am not sick. You can keep me here longer to monitor me if you wish. The meds make me sick and all I am asking is for an opportunity. I was depressed because I felt alone and nobody understands me. But I am seeing that there are people out there like me, just not as many. I want to be myself, which is why I use drugs and alcohol – it sets me free. Then I get more depressed and feel that life is not worth living. It has nothing to do with a disorder, I have just felt rejected and keep being told that I am not normal. But that's ok, too. I'm not even sure I would want to be normal."

The psychiatric team told him they would consider what he had said, but as soon as he left of the room, they burst into collective laughter. I know this because I was there. I was horrified but not surprised.

During his stay, I befriended Jacob and felt a real connection with him. I found him to be a highly sensitive and intelligent young man. He realized he must do as they told him so he would be granted his discharge and move on with his life. He was doped up with medications that made him sleep all day and, rendered inactive by the drugs that were forced upon him, he gained 20 pounds in just a few weeks. Worst of all, he no longer talked about the things that brought him joy and energy.

As far as the psychiatric staff were concerned, Jacob no longer displayed "psychotic symptoms" which, in their eyes, meant that he was clinically making progress. As his symptom diminished, the staff patted themselves on the back for "curing" this poor child, and the family was happy to have 'saved normal'.

As for me? I was furious! This was simply not right. This child was intelligent, bright, and naturally gifted, and the "mental health" establishment took that away from him, and outwardly congratulated themselves for doing so.

But, when we scratch the surface of psychiatric institutions, the sad reality is that most psychiatric physicians are inadequately trained even to prescribe the psychotropic medications they so commonly substitute for genuine care — and deep down, they know it.

Dr. Marianne Kuzujanakis, MD, MPH, is a pediatrician with a Masters in Public Health from Harvard, the Director of SENG (Supporting Emotional Needs of the Gifted) and a co-Founder of the SENG Misdiagnosis Initiative. In an article for Psychology Today she described this problem as follows:

Pediatric primary care physicians do much of the psychiatric diagnosis and prescribe most of the psychotropic medicine – but a recent survey showed that only 10% felt adequately prepared by their training to do so. They see these kids for very brief visits, and many are too influenced by drug marketing propaganda – as are parents and teachers. Over-diagnosis and over-treatment are commonplace.

Dr. Kuzujanakis went on to state that pediatric misdiagnoses of ADHD, autism, depressive disorders and bipolar disorder are often attributed to highly gifted individuals; and at the same time, other symptoms go unrecognized, such as learning disabilities in those who do genuinely have them.

Dr. Kuzujanakis also asserts that giftedness does not always equate to what our society deems "positive" experiences. In fact, up to 20% of gifted adolescents drop out of the school system, displaying such "symptoms" as talking a lot, high energy levels, and impulsive, inattentive, or distractable behaviours. [10] Notably, these symptoms of the gifted are remarkably close to the symptoms of a person experiencing the manic pole of the bipolar disorder. And they are the same behaviors I observed in young Jacob, whose only desire was "to travel the world, be a vagabond, read, write, and draw."

Where Is Jacob Now?

Today, Jacob has a family of his own, lives in the country, spends time in nature and makes enough money to pay the bills. He spends most of his time with his beautiful children, teaching them about life and what he feels is most important. He did end up traveling the world, roughing it with almost no money in his pocket — and he got to experience how other cultures lived, as was his dream.

Jacob rarely sees his immediate family these days, other than at occasional family reunions at which he regularly hears condescendingly mutters about 'how bad they feel for him and his family'. But Jacob is happy. He knows who he is, and although his family does not understand this, it is Jacob who feels badly for them. While he now enjoys all aspects of the life he has created for himself, they – like most of us – continue to live behind their masks of 'normalcy'.

So I ask you… Who is the crazy one?

Taking the Mask Off: Destroying the Stigmatic Barriers of Mental Health and Addiction Using a Spiritual Solution

taking-the-mask-off-stigma-barriers-mental-health-addiction-spiritual-solution

"Taking the Mask Off" is the new book by Cortland Pfeffer and Irwin Ozborne. Cortland Pfeffer spent years as a patient in psychiatric hospitals, treatment centers, and jails before becoming a registered nurse and working in the same facilities. Based on his experience, this story is told from both sides of the desk. It offers a unique and valuable perspective into mental health and addiction, revealing the problems with the psychiatric industry while also providing the solution – one that brings together science, spirituality, philosophy, and personal experience.

"Taking the Mask Off: Destroying the Stigmatic Barriers of Mental Health and Addiction Using a Spiritual Solution" is available on Amazon, and Balboa Press.

About the authors:

Cortland Pfeffer founded his website Taking The Mask Off in 2014 to help shine a light on the mental health industry. Sharing insider perspectives and real life stories that have been gathered over 20 years in the field, Cortland (a pen-name) is a psychiatric Registered Nurse who was himself once a patient in psychiatric hospitals, jails, and treatment centers. He now wishes to share his experiences with others, and has recently made several public speaking appearances. Cortland can be contacted for speaking engagements through his website Taking The Mask Off. You can also follow Cortland via his YouTube channel and www.facebook.com/takingthemaskoff.

This article was co-written by Cortland's partner Irwin Ozborne (also a pen-name), who is also a contributing writer for Taking The Mask Off. A survivor of childhood abuse and torture over a period of 13 years, and a recovered alcoholic, Irwin is now a Mental Health Practitioner and Public Speaker. He practices holistic care and incorporates eastern philosophy into his work with clients. He is available for speaking engagements as well and can be contacted via email: takingmaskoff@yahoo.com

You can follow Cortland and Irwin at:

Recommended articles by Cortland and Irwin:

References:

  1. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 2005 Jun;62(6):617-27. http://www.ncbi.nlm.nih.gov/pubmed/15939839
  2. Bipolar Disorder in Adults. (2012). National Institute of Mental Health – NIH Publication No. 12-3679. http://www.nimh.nih.gov/health/publications/bipolar-disorder-in-adults/index.shtml
  3. Harris, G. (2011, March 5). Talk Doesn't Pay, So Psychiatry Turns Instead to Drug Therapy. New York Times. http://www.nytimes.com/2011/03/06/health/policy/06doctors.html?pagewanted=all&_r=0
  4. George, W. (1969). Manic Depressive Illness. Maryland Heights, Missouri: C.V. Mosby. http://garfield.library.upenn.edu/classics1980/A1980JF47000001.pdf
  5. World Drug Situation 1988 and IMS Health, IMS MIDAS Customized Insights (October 2001) The information contained in this study is a guide to sales and not a guide to consumption. http://apps.who.int/medicinedocs/en/d/Js6160e/6.html
  6. Merikangas KR, Jin R, He J, et al. Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry. 2011;68(3):241-251. doi:10.1001/archgenpsychiatry.2011.12. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486639/
  7. Food and Drug Administration Guidance for Industry: Consumer-Directed Broadcast Advertisements. Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm125064.pdf.
  8. Sandy, S. (2014, August 15). Better Off Without Antipsychotic Drugs? Psychiatric Times. http://www.psychiatrictimes.com/psychopharmacology/letters-editor-response-better-without-antipsychotic-drugs/page/0/2
  9. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M . National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry. 2007 Sep;64(9). http://www.ncbi.nlm.nih.gov/pubmed/17768268
  10. Frances, D. (2013, March 14). Giftedness Should Not Be Confused With Mental Disorder. https://www.psychologytoday.com/blog/saving-normal/201303/giftedness-should-not-be-confused-mental-disorder

Related reading:

Header image by Jeffery Foti.






Did you find this article helpful?

If so, please consider a donation to help the evolution of Wake Up World and show your support for alternative media.

Your generosity is greatly appreciated.

Wake Up World's latest videos





Elyssa D. Durant 
Research & Policy Analyst